Merus

About:

Merus is a biomedical company engaged in the discovery and development of antibody-based biopharmaceuticals.

Website: http://www.merus.nl

Twitter/X: MerusNV

Top Investors: Pfizer, RA Capital Management, Sofinnova Investments, Novo Holdings, Biotechnology Value Fund

Description:

Merus B.V., a biomedical company, engages in the discovery and development of antibody-based biopharmaceuticals. It develops Oligoclonics technology that offers a class of human antibodies called Oligoclonics. Oligoclonics is a concept whereby a mixture of various human therapeutic antibodies, directed to a common antigen are produced from a single cell clone.